Elena Dzhambazova

Prof. Dr. Elena Dzhambazova

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
IJIbtissem Jlalia
Ibtissem Jlalia
LNLensen Nathalie
Lensen Nathalie
GCGrégory Chaume
Grégory Chaume
EDElena Dzhambazova
Elena Dzhambazova
LALiountmila Astasidi
Liountmila Astasidi
TBThierry Brigaud
Thierry Brigaud

1 October 2018 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
Petar Todorov TodorovPetar Todorov Todorov
Petar Todorov Todorov
PPPetia Peneva
Petia Peneva
DPDaniela Pechlivanova
Daniela Pechlivanova
Stela GeorgievaStela Georgieva
Stela Georgieva
EDElena Dzhambazova
Elena Dzhambazova

1 December 2017 in Journal of Chemical Neuroanatomy
Verified
Journal Article
Closed access
BLBoycho Landzhov
Boycho Landzhov
DHDimka Hinova-Palova
Dimka Hinova-Palova
LELawrence Edelstein
Lawrence Edelstein
EDElena Dzhambazova
Elena Dzhambazova
IBIlina Brainova
Ilina Brainova
WOWladimir Ovtscharoff
Wladimir Ovtscharoff

13 September 2019 in Amino Acids
Verified
Journal Article
Closed access
PDF file
HAHristina Angelova
Hristina Angelova
DPDaniela Pechlivanova
Daniela Pechlivanova
EKEkaterina Tz Krumova
Ekaterina Tz Krumova
JMJeny Miteva-Staleva
Jeny Miteva-Staleva
NKNedelina Kostadinova
Nedelina Kostadinova
BLBoycho Landzhov
Boycho Landzhov

1 January 2020 in Bratislava Medical Journal
Verified
Journal Article
Closed access
SSS. Stanchev
S. Stanchev
NSN. Stamenov
N. Stamenov
VKV. Kirkov
V. Kirkov
EDElena Dzhambazova
Elena Dzhambazova
DND. Nikolov
D. Nikolov
APA. Paloff
A. Paloff
Differential collagen expression in kidney and heart during hypertension

19 May 2021 in Protein & Peptide Letters
Verified
Journal Article
Closed access
PDF file
BABorislav Assenov
Borislav Assenov
DPDaniela Pechlivanova
Daniela Pechlivanova
EDElena Dzhambazova
Elena Dzhambazova
PPPetia Peneva
Petia Peneva
Petar Todorov TodorovPetar Todorov Todorov
Petar Todorov Todorov
Background: Hemorphins are endogenous hemoglobin-derived peptides that belong to the family of “atypical” opioid peptides with both affinities to opioid receptors and ability to release other endogenous opioid peptides. Objective: In the present study, peptide analogues of Valorphin (VV-hemorphin-5) containing amino phosphonate moiety synthesized by solid-phase peptide synthesis (Fmoc-strategy) were investigated for their potential antinociceptive activities and compared to the reference VV-H in formalin- induced model of acute and inflammatory pain in mice. Methods: The hemorphin analogues were prepared by replacement of the one and/or two N-terminal Val in VV-hemorphin5 (VV-H) with ((dimethoxy phosphoryl) methyl)-L-valine and ((dimethoxy phosphoryl) methyl)-L-leucine to obtain the compounds pVV-H, pL-H, and pLV-H. Aiming to additionally prove the importance of amino acid valine, we introduced the ((dimethoxy phosphoryl) methyl)-L-leucine to the N-side of VV-hemorphin-5 (pLVV-H). The experiments were carried out on adult male ICR mice. All peptides were administered intracerebroventricularly at three doses (50, 25 and 12,5 μg/mouse). We have studied the effects of the peptides on acute (1st phase) and inflammatory (2nd phase) pain reaction using un experimental model with intraplantar formalin injection. Results: VV-H showed a significant antinociceptive effect both in the acute and inflammatory phases of the test. Although Valorphin hexa-, hepta-, and octapeptide analogs demonstrated a significant antinociceptive effect, they showed substantial differences considering their effective dose and the phase of the test as compared to the Valorphin. Discussion: Data showed that modified heptapeptides pVV-H and pLV-H exerted the same or better antinociception in acute and inflammatory pain, in comparison to the reference peptide, while pL-H and pLVV-H analogues were less effective. Conclusion: Our study contributes to the elucidation of the role of Valine and the number of amino acid residues in the structure of hemorphin peptide analogs in their effectiveness in suppressing both acute and inflammatory experimental pain.